SciLifeLab Innovations – Pharma & Biotech

A national drug discovery collaboration.

Are you a scientific researcher or investing in translational research for new therapeutic treatments? SciLifeLab and the innovation support systems are collaborating to facilitate the discovery of new pharma and biotech therapeutics based on frontline academic research at Swedish Universities. SciLifeLab harbors advanced research infrastructures in which the Drug Discovery and Development platform (DDD) is the spearhead for knowhow and wet lab support in academic drug discovery.

The most promising projects from swedish academic scientific research are selected for resourcing as drug discovery projects. Innovation support is provided by the university innovation support system and the three parties (the principal investigator at the university, SciLifeLab DDD and the innovation support system) forms a joint project team to identify new protype drugs that can be further developed into treatment for patients. In accordance with the Swedish teachers exemption law, the academic scientist retain all intellectual rights to the prototype drug.

The ultimate goal with this three party collaboration is to provide the swedish life science community with cutting edge technologies for drug discovery research and to generate the highest possible quality and revenue of investments in basic life science research in terms of patient benefits, health care, and life science innovations which is also competitive at an international level.